|
Space Suits
|
J01.637.215.600.700 |
|
|
Protective Clothing
|
J01.637.215.600 |
|
|
Vascular Endothelial Growth Factor Receptor-2
|
D12.776.543.750.630.750.200 |
|
|
Receptors, Vascular Endothelial Growth Factor
|
D12.776.543.750.630.750 |
|
|
Preservatives, Pharmaceutical
|
D011310 |
[Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants.
] |
|
U937 Cells
|
A11.627.482.665.500 |
|
|
Monocyte-Macrophage Precursor Cells
|
A11.627.482.665 |
|
|
Pressoreceptors
|
D011311 |
[Receptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls.
] |
|
Pneumonia, Mycoplasma
|
C08.381.677.540.500 |
|
|
Leukocyte Migration-Inhibitory Factors
|
D23.125.477 |
|
|
TYK2 Kinase
|
D12.776.476.393.650 |
|
|
Fusobacteriaceae Infections
|
C01.150.252.400.388 |
|
|
Anus Neoplasms
|
C06.405.469.860.101.163 |
|
|
Anus Diseases
|
C06.405.469.860.101 |
|
|
I-kappa B Kinase
|
D08.811.913.696.620.682.700.494 |
|
|
Complement C3
|
D12.776.124.486.274.250 |
|
|
Periapical Abscess
|
C07.465.714.306.700.700 |
|
|
Hematoma, Epidural, Cranial
|
C23.550.414.838.349 |
|
|
Toxoplasmosis, Ocular
|
C01.610.752.250.800.640 |
|
|
Foot Deformities, Acquired
|
C05.330.488 |
|
